Pfizer will continue to manufacture, source and supply these medicines to Cipla for India. Previous Post NBCC wins ₹179 crore PMC contract for IIM Sambalpur campus expansion Next Post Shriram Finance deal takes India's financial sector investments past $11 billion in 2025 Leave a ReplyCancel ReplyYour email address will not be published. Required fields are marked * Name * Email * Website Add Comment * Save my name, email, and website in this browser for the next time I comment.Post Comment
